National Comprehensive Cancer Network



About NCCN

Adolescent and Young Adult Oncology Panel - Disclosures as of 5/18/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jessica Altman, MD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
Astellas;
Clavis;
Cyclacel;
CytRx

Celgene Corporation;
Astellas;
Teva

None

None

8/14/2012

Smita Bhatia, MD, MPH

None

None

None

None

3/10/2012

Scott C. Borinstein, MD, PhD

None

None

None

None

11/28/2012

Peter F. Coccia, MD

None

None

None

None

12/21/2012

Joseph Flynn, DO, MPH

None

None

None

None

8/9/2012

Suzanne George, MD

Bayer HealthCare;
Eisai Inc.;
Johnson & Johnson

Pfizer Inc.

None

None

3/8/2012

Robert Goldsby, MD

None

None

None

None

3/25/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Robert Hayashi, MD

None

National Childrens Cancer Society

None

None

4/1/2013

Mary S. Huang, MD

None

None

None

None

2/15/2013

Rebecca H. Johnson, MD

None

None

None

None

4/27/2012

Lynda Kwon Beaupin, MD

None

None

None

None

3/25/2013

Michael P. Link, MD

Novartis Pharmaceuticals Corporation;
Affymetrix;
Seattle Genetics

None

None

None

3/25/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Kevin C. Oeffinger, MD

None

None

None

None

3/25/2013

Kathleen M. Orr, MSW, LCSW-C

None

None

None

None

7/11/2012

Alberto S. Pappo, MD

None

None

None

None

5/1/2013

Damon Reed, MD

None

None

None

None

6/21/2012

Dorothy Shead, MS

None

None

None

None

8/3/2012

Holly L. Spraker, MD, MS

None

None

None

None

11/27/2012

Hema Sundar, PhD

None

None

None

None

2/25/2013

Deborah A. Thomas, MD

None

None

None

None

7/25/2012

Margaret von Mehren, MD

Eisai Inc.;
Johnson & Johnson;
Merck & Co., Inc.;
Morphotek Inc.;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
OSI Pharmaceuticals, Inc.;
Arog Pharmaceuticals;
Astex;
Infinity;
Pharma Mar;
Sarcoma Alliance for Research through Collaboration;
Pfizer Inc.;
Synta Pharmaceuticals Corp.

Eisai Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Pharma Mar;
Pfizer Inc.

None

None

8/6/2012

Daniel S. Wechsler, MD, PhD

None

None

None

None

3/26/2013

Kimberly F. Whelan, MD

None

None

None

None

8/6/2012

Bradley J. Zebrack, PhD, MSW, MPH

None

None

None

None

11/15/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved